Rochester, MN, United States of America

Balmiki Ray

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duke University, Ixcela, Inc., Mayo Foundation for Medical Education and Research. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balmiki Ray. Retrieved from https://idiyas.com/inventor/balmiki-ray

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Balmiki Ray: A Pioneer in Treating Major Depressive Disorder

Introduction

Balmiki Ray, an innovative inventor based in Rochester, MN, has made significant contributions to the medical field. With a focus on treating major depressive disorder, Ray has developed a unique approach that modulates the aryl hydrocarbon receptor system.

Latest Patents

Balmiki Ray holds one patent, titled "Modulating the aryl hydrocarbon receptor system to treat major depressive disorder." This patent includes materials and methods designed to treat this complex mental health condition by targeting the aryl hydrocarbon receptor system.

Career Highlights

Ray has had a distinguished career, contributing his expertise to organizations such as the Mayo Foundation for Medical Education and Research and Ixcela, Inc. His work in these reputable institutions exemplifies his commitment to advancing mental health treatment.

Collaborations

Throughout his career, Balmiki Ray has collaborated with notable colleagues, including Liewei Wang and Joanna Biernacka. These partnerships have further enriched his background and have played a role in the development of innovative solutions in his field.

Conclusion

Balmiki Ray stands out as a dedicated inventor in the realm of medical research. His patent and collaborations showcase his commitment to developing new treatments for major depressive disorder, highlighting the vital role of innovation in improving mental health care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…